Overexpression of Ku80 is associated with an adverse prognosis in ESCC [162], a cancer type that is not classified as HNC but which is often accompanied by head and neck second primary tumors (in approximately 7% of ESCCs patients) [163]. This evidence concerns the gene XRCC5 and cancer.